Cargando…
Localization of GPSM2 in the Nucleus of Invasive Breast Cancer Cells Indicates a Poor Prognosis
Purpose: GPSM2 (G protein signaling modulator 2) was reported to be involved in the cell division of breast cancer cells. Additionally, cytoplasmic dynein may mediate the transport process of GPSM2. DYNC1I1 (Cytoplasmic dynein 1 intermediate chain 1) is the most common cargo-binding subunit of dynei...
Autores principales: | Deng, Mingming, Zhang, Zhe, Liu, Bofang, Hou, Kezuo, Che, Xiaofang, Qu, Xiujuan, Liu, Yunpeng, Hu, Xuejun, Zhang, Ye, Lv, Qingjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063060/ https://www.ncbi.nlm.nih.gov/pubmed/32195179 http://dx.doi.org/10.3389/fonc.2020.00227 |
Ejemplares similares
-
Downregulation of GPSM2 is associated with primary resistance to paclitaxel in breast cancer
por: Zhang, Zhe, et al.
Publicado: (2020) -
Knockdown of G‐protein‐signaling modulator 2 promotes metastasis of non‐small‐cell lung cancer by inducing the expression of Snail
por: Deng, Mingming, et al.
Publicado: (2020) -
M2 macrophage infiltration into tumor islets leads to poor prognosis in non-small-cell lung cancer
por: Cao, Lili, et al.
Publicado: (2019) -
Assessment of Nine Driver Gene Mutations in Surgically Resected Samples from Patients with Non-Small-Cell Lung Cancer
por: Wang, Shuo, et al.
Publicado: (2020) -
Elevated limb-bud and heart development (LBH) expression indicates poor prognosis and promotes gastric cancer cell proliferation and invasion via upregulating Integrin/FAK/Akt pathway
por: Yu, Ruoxi, et al.
Publicado: (2019)